HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 06, June 2017 – Advocacies in Support of Rare Disease Patients       » Bayer and NUS Enterprise Announce Winners of Grants4Apps? Singapore Open Innovation Challenge       » Cancer Control Efforts in Vietnam: Interview with Dr Tran Thanh Huong       » China Sets up National Lab Developing Brain-Like AI Technology       » New Womb-Like Invention for Preterm Infants       » World Asthma Day: Managing and Living with Asthma       » Managing Liver Cancer as a Global Health Problem      
BIOBOARD - INSIDE INDUSTRY
Yakult Honsha and JAXA collaborate on research of the effect by probiotics on human immune function and gut microbiota
Yakult Honsha and Japan Aerospace Exploration Agency (JAXA) have reached an agreement to start a joint research in the International Space Station (ISS).

This research hopes to contribute to the health care of astronauts and the development of life science in the coming space age by scientifically studying the effect by probiotics on human immune function and gut microbiota of astronauts, who stay in space for long periods. It is also aimed at making contributions to promote people's health in general by utilizing the knowledge thus gained in the joint research for development of probiotics research on the ground.

The key research items are detailed below.

  • Study of the effect by probiotics on human immune function and gut microbiota in a microgravity environment in a confined microgravity environment (space)

  • Assessing the on-board safety, operability of live bacteria (Lactobacillus casei strain Shirota) and acquisition of related technical knowledge
Astronauts work in space, which is an extreme working environment of microgravity inside a closed spacecraft, and they are known to experience deterioration of immune function as well asbone density and muscular atrophy. In order to ensure a successful manned space flight, it is necessary to maintain the mental and physical health of the astronauts to enable them to fully demonstrate their capability. As one of the measures to tackle such issues, JAXA has been examining utilization of functional space food incorporating probiotics among other ingredients. Space development organizations in other countries are also about to embark on similar research.

For these reasons, Yakult and JAXA reached an agreement to embark on the joint research on probiotics in humans in space ahead of other countries.

The joint research is aimed at scientific examination of the influence of continuous consumption on the immune function and gut microbiota of astronauts stationed at ISS for a long period. They are also aiming to expand its scope to study how the impact of probiotic changes in outer space. The joint research, which combines the expertise Yakult has acquired over the years in gut microbiota research with JAXA's space biomedical research-related knowledge and laboratory technique in space, aims to not only allow astronauts to demonstrate their capabilities to the full extent but also contribute to the advancement of space medicine, often termed as ultimate preventive medicine, which is also expected to be applied on the ground.

Click here for the complete issue.

NEWS CRUNCH  
news The Seventh International Meeting on Synthetic Biology (SB 7.0)
news Healthcare Sustainability in Asia: Now is the Time to Act — FT Asia Healthcare & Life Sciences Summit 2017
news Philip Morris International and British American Tobacco receive award from PETA science group for AOP developments
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye Care/ Eye Health
September:
Emerging Infectious Diseases
October:
No. 1 Killer — Heart Diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy